Christopher M. Parker

Chris is a litigation associate who maintains a focus on the Health Care and Life Sciences sector. He regularly advises health care clients on regulatory matters, including those involving federal controlled substance regulations and risk management.  Chris is highly experienced in navigating the intricate complexities of compliance with the Controlled Substances Act, particularly during investigations initiated by the Drug Enforcement Administration.

In addition to advising clients on regulatory matters, Chris has substantial experience defending clients in connection with a wide range of issues arising under both criminal and civil statutes. These include the False Claims Act (FCA) and related qui tam/whistleblower litigation, government program fraud, the Anti-Kickback Statute, health care fraud, and government contracting fraud.

Chris also counsels clients on the development and enhancement of compliance programs, providing strategic guidance for achieving compliance objectives and minimizing the risk of government investigations. He has successfully defended financial services institutions in complex commercial litigation and government investigations, including class actions, mass tort, and contractual disputes.  Chris is experienced in all phases of litigation, including case assessment and strategy development, briefing and arguing motions, and managing all aspects of discovery in complex litigation. He is skilled in defending and taking depositions, as well as preparing cases and witnesses for trial.